No Prescription » Prescription Drugs 15 » Synthroid Generic Levothyroxine
Synthroid« (levothyroxine sodium tablets USP) is a synthetic thyroid hormone intended to replace a hormone that is normally produced by your thyroid gland. Generally thyroid replacement therapy is to be taken for life.SYNTHROID should not be used for weight loss. Talk to your doctor about any medication and food allergies all medications you are taking pregnancy plans and all medical conditions you may have especially heart disease clotting disorders and adrenal or pituitary gland problems. Tell your doctor if you experience: rapid or irregular heartbeat chest pain shortness of breath leg cramps headache nervousness irritability sleeplessness tremors change in appetite weight gain or loss vomiting diarrhea excessive sweating heat intolerance fever changes in menstrual periods hives or skin rash or any other unusual medical event.
Buy Synthroid Generic Levothyroxine and other Prescription Drugs 15 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Synthroid Generic Levothyroxine:
Product Type: Prescription Drugs 15
Synthroid (Generic Levothyroxine) Product Origin: Canada
Synthroid (Generic Levothyroxine)
Generic Levothyroxine
100mcg 100 Tablets 100mcg 200 Tablets 100mcg 400 Tablets 112mcg 100 Tablets 112mcg 200 Tablets 112mcg 400 Tablets 125mcg 100 Tablets 125mcg 200 Tablets 125mcg 400 Tablets 137mcg 100 Tablets 137mcg 200 Tablets 137mcg 400 Tablets 150mcg 100 Tablets 150mcg 200 Tablets 150mcg 400 Tablets 175mcg 100 Tablets 175mcg 200 Tablets 175mcg 400 Tablets 200mcg 100 Tablets 200mcg 200 Tablets 200mcg 400 Tablets 25mcg 100 Tablets 25mcg 200 Tablets 25mcg 400 Tablets 50mcg 200 Tablets 50mcg 400 Tablets 50mcg 100 Tablets 75mcg 100 Tablets 75mcg 200 Tablets 75mcg 400 Tablets 88mcg 100 Tablets 88mcg 200 Tablets 88mcg 400 Tablets
Generic Levothyroxine Synthroid

View more
Prescription Drugs 15
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|